Chapter 1. Research Framework

1.1 Research Objective

1.2 Product Overview

1.3 Market Segmentation

Chapter 2. Research Methodology

2.1 Qualitative Research

2.1.1 Primary & Secondary Sources

2.2 Quantitative Research

2.2.1 Primary & Secondary Sources

2.3 Breakdown of Primary Research Respondents, By Region

2.4 Assumption for the Study

2.5 Market Size Estimation

2.6. Data Triangulation

Chapter 3. Executive Summary: Global Preclinical Brain Imaging Market

Chapter 4. Global Preclinical Brain Imaging Market Overview

4.1. Industry Value Chain Analysis

4.1.1. OEMs

4.1.2. Service Provider

4.1.3. Supply & Distribution

4.1.4. End-Users

4.2. Industry Outlook

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis

4.4.1. Bargaining Power of Suppliers

4.4.2. Bargaining Power of Buyers

4.4.3. Threat of Substitutes

4.4.4. Threat of New Entrants

4.4.5. Degree of Competition

4.5. Market Dynamics and Trends

4.5.1. Growth Drivers

4.5.2. Restraints

4.5.3. Opportunities

4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook

4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2030

4.7.2. Price Trend Analysis

4.8. Competition Dashboard

4.8.1. Market Concentration Rate

4.8.2. Company Market Share Analysis (Value %), 2020

4.8.3. Competitor Mapping

Chapter 5. Global Preclinical Brain Imaging Market, By Imaging Type

5.1. Key Insights

5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

5.2.1. Computed Tomography (CT)

5.2.2. Magnetic Resonance Imaging (MRi)

5.2.3. Positron Emission Tomography (PET)

5.2.4. Single Photon Emission Computed Tomography (SPECT)

Global Preclinical Brain Imaging Market, By End User

5.3. Key Insights

5.4. Market Size and Forecast, 2017 - 2030 (US$ Mn)

5.4.1. Pharma and Biotech Companies

5.4.2. Contract research organization (CRO's)

5.4.3. Education & Research Institutes

Global Preclinical Brain Imaging Market Analysis, By Region

5.5. Key Insights

5.6. Market Size and Forecast, 2017 - 2030 (US$ Mn)

5.6.1. North America

5.6.1.1. The U.S.

5.6.1.2. Canada

5.6.1.3. Mexico

5.6.2. Europe

5.6.2.1. Western Europe

5.6.2.1.1. The UK

5.6.2.1.2. Germany

5.6.2.1.3. France

5.6.2.1.4. Italy

5.6.2.1.5. Spain

5.6.2.1.6. Rest of Western Europe

5.6.2.2. Eastern Europe

5.6.2.2.1. Poland

5.6.2.2.2. Russia

5.6.2.2.3. Rest of Eastern Europe

5.6.3. Asia Pacific

5.6.3.1. China

5.6.3.2. India

5.6.3.3. Japan

5.6.3.4. South Korea

5.6.3.5. Australia & New Zealand

5.6.3.6. ASEAN

5.6.3.7. Rest of Asia Pacific

5.6.4. Middle East & Africa (MEA)

5.6.4.1. UAE

5.6.4.2. Saudi Arabia

5.6.4.3. South Africa

5.6.4.4. Rest of MEA

5.6.5. South America

5.6.5.1. Brazil

5.6.5.2. Argentina

5.6.5.3. Rest of South America

Chapter 6. North America Preclinical Brain Imaging Market Analysis

6.1. Key Insights

6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

6.2.1. By Imaging Type

6.2.2. By End User

6.2.3. By Country

US Preclinical Brain Imaging Market Analysis

6.3. Key Insights

6.4. Market Size and Forecast, 2017 - 2030 (US$ Mn)

6.4.1. By Imaging Type

6.4.2. By End User

Chapter 7. Europe Preclinical Brain Imaging Market Analysis

7.1. Key Insights

7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

7.2.1. By Imaging Type

7.2.2. By End User

7.2.3. By Country

Chapter 8. Asia Pacific Preclinical Brain Imaging Market Analysis

8.1. Key Insights

8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

8.2.1. By Imaging Type

8.2.2. By End User

8.2.3. By Country

Chapter 9. South America Preclinical Brain Imaging Market Analysis

9.1. Key Insights

9.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

9.2.1. By Imaging Type

9.2.2. By End User

9.2.3. By Country

Chapter 10. Middle East & Africa Preclinical Brain Imaging Market Analysis

10.1. Key Insights

10.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)

10.2.1. By Imaging Type

10.2.2. By End User

10.2.3. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, Measurement Methods and Business Strategy Outlook)

11.1. Acadia Healthcare

11.2. The MENTOR Network

11.3. Universal Health Services, Inc.

11.4. Behavioral Health Network, Inc.

11.5. CareTech Holdings PLC

11.6. Ascension Seton

11.7. Pyramid Healthcare

11.8. Promises Behavioral Health